Siklos 1 000 mg film-coated tablet.

DRUG2 trials

Sponsors

Novo Nordisk A/S, Les Hopitaux Universitaires De Strasbourg

Conditions

DrepanocytosisSickle cell disease

Phase 2

A multicentre trial evaluating the efficacy and safety of oral decitabine-tetrahydrouridine (NDec) in patients with sickle cell disease

CompletedCTIS2023-508506-22-00

Novo Nordisk A/SSickle cell disease

Start: 2022-09-22End: 2025-05-07Target: 15Updated: 2024-12-19

Phase 4

Optimization of the management of drepanocytosis patients treated with hydroxyurea: Interest of the pharmacological therapeutic follow-up

CompletedCTIS2024-515562-14-00

Les Hopitaux Universitaires De StrasbourgDrepanocytosis

Start: 2024-07-19End: 2025-10-27Target: 30Updated: 2024-07-19